Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions

European Journal of Internal Medicine

Volumn 23, Issue 5, 2012, Pages 447-450

  Porcel, José M ^a   Bielsa, Silvia ^a   Esquerda, Aureli ^a   Ruiz González, Agustín ^a   Falguera, Miquel ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

C reactive protein; Empyema; Parapneumonic effusion; Pleural fluid

Indexed keywords

ADENOSINE DEAMINASE; C REACTIVE PROTEIN; GLUCOSE; LACTATE DEHYDROGENASE; PROTEIN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; HUMAN; MAJOR CLINICAL STUDY; NEUTROPHIL; PARAPNEUMONIC EFFUSION; PH; PLEURA EFFUSION; PLEURA FLUID; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; C-REACTIVE PROTEIN; EXUDATES AND TRANSUDATES; HUMANS; MIDDLE AGED; PLEURAL EFFUSION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84862996085     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2012.03.002     Document Type: Article

References (14)

1. Brixey AG, Luo Y, Skouras V, Awdankiewicz A, Light RW. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology 2011;16:1000-4.
2. Porcel JM. Pearls and myths in pleural fluid analysis. Respirology 2011;16:44-52.
3. Tung A, Bilaceroglu S, Porcel JM, Creaney J, Gary Lee YC. Biomarkers in pleural diseases. US. Respir Med 2011;7:26-31.
4. Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-González A, Martínez-Iribarren A, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009;34:1383-9.
5. Light RW. Clinical practice. Pleural effusion. N Engl J Med 2002;8:308-11.
6. Chalmers JD, SinganayagamA,Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008;121:219-25.
7. Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax 2009;64:592-7.
8. Yilmaz Turay U, Yildirim Z, Türköz Y, Biber C, Erdoǧan Y, Keyf AI, et al. Use of pleural fluid C-reactive protein in diagnosis of pleural effusions. Respir Med 2000;94:432-5.
9. Daniil ZD, Zintzaras E, Kiropoulos T, Papaioannou AI, Koutsokera A, Kastanis A, et al. Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J 2007;30:957-64.
10. Kiropoulos TS, Kostikas K, Oikonomidi S, Tsilioni I, Nikoulis D, Germenis A, et al. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med 2007;101:910-8.
11. San José ME, Valdés L, Vizcaíno LH, Mora T, Pose A, Soneira E, et al. Procalcitonin, C-reactive protein, and cell counts in the diagnosis of parapneumonic pleural effusions. J Investig Med 2010;58:971-6.
12. Chen SC, ChenW, Hsu WH, Yu YH, Shih CM. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema. Lung 2006;184:141-5.
13. Porcel JM, Galindo C, Esquerda A, Trujillano J, Ruiz-González A, Falguera M, et al. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated nonpurulent from uncomplicated parapneumonic effusions. Respirology 2008;13:58-62.
14. Porcel JM, Vives M, Esquerda A, Ruiz A. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions. Respir Med 2006;100:933-7.